{"id":2402,"date":"2018-10-02T00:00:00","date_gmt":"2018-10-02T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2402"},"modified":"2018-10-02T00:00:00","modified_gmt":"2018-10-02T00:00:00","slug":"centogene%e3%81%a8denali-therapeutics%e3%81%af%e3%80%81lrrk2%e6%82%a3%e8%80%85%e3%81%ae%e8%87%a8%e5%ba%8a%e8%a9%a6%e9%a8%93%e3%81%b8%e3%81%ae%e5%8f%82%e5%8a%a0%e3%82%92%e5%8b%9f%e3%82%8b%e3%81%9f","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/jp\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\/","title":{"rendered":"CENTOGENE\u3068DENALI THERAPEUTICS\u306f\u3001LRRK2\u60a3\u8005\u306e\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u53c2\u52a0\u3092\u52df\u308b\u305f\u3081\u306e\u6226\u7565\u7684\u63d0\u643a\u3092\u767a\u8868\u3057\u305f\u3002"},"content":{"rendered":"<p>CENTOGENE\u3068Denali Therapeutics\uff08NASDAQ\uff1aDNLI\uff09\u306f\u672c\u65e5\u3001LRRK2\u907a\u4f1d\u5b50\u5909\u7570\u3092\u6709\u3059\u308b\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\uff08PD\uff09\u60a3\u8005\u306e\u4e16\u754c\u7684\u306a\u7279\u5b9a\u3068\u52df\u96c6\u306b\u95a2\u3059\u308b\u6226\u7565\u7684\u63d0\u643a\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002.<\/p>\n<p>CENTOGENE\u306f\u3001LRRK2 PD\u60a3\u8005\u306e\u65e9\u671f\u767a\u898b\u3068\u7279\u5fb4\u4ed8\u3051\u306b\u7126\u70b9\u3092\u5f53\u3066\u305f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u88ab\u9a13\u8005\u52df\u96c6\u30ad\u30e3\u30f3\u30da\u30fc\u30f3\u3092\u5b9f\u65bd\u3057\u3001\u3053\u308c\u3089\u306e\u60a3\u8005\u306eLRRK2\u907a\u4f1d\u5b50\u306e\u914d\u5217\u3092\u89e3\u6790\u3057\u307e\u3059\u3002\u5951\u7d04\u6761\u4ef6\u306b\u57fa\u3065\u304d\u3001CENTOGENE\u306f <a href=\"https:\/\/www.centogene.com\/jp\/%e9%81%ba%e4%bc%9d%e5%ad%90%e6%a4%9c%e6%9f%bb\/how-to-order\/filtercard-centocard.html\/\" target=\"_blank\" title=\"CentoCard\u306b\u3064\u3044\u3066\u3082\u3063\u3068\u8a73\u3057\u304f\">CentoCard\u00ae<\/a>, \u540c\u793e\u306f\u3001\u72ec\u81ea\u306e\u691c\u8a3c\u6e08\u307f\u4e7e\u71e5\u8840\u6db2\u30b9\u30dd\u30c3\u30c8\u63a1\u53d6\u30ad\u30c3\u30c8\u3092\u7528\u3044\u3066\u3001LRRK2\u907a\u4f1d\u5b50\u306b\u5909\u7570\u3092\u6301\u3064\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u60a3\u8005\u3092\u7279\u5b9a\u3057\u3001\u30c7\u30ca\u30ea\u793e\u306e\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u53c2\u52a0\u3092\u52df\u308b\u3002.<\/p>\n<p>LRRK2\u907a\u4f1d\u5b50\u306e\u5909\u7570\u306f\u3001\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u306e\u6700\u3082\u4e00\u822c\u7684\u306a\u907a\u4f1d\u7684\u539f\u56e0\u306e\u4e00\u3064\u3067\u3042\u308a\u3001\u30ea\u30bd\u30bd\u30fc\u30e0\u6a5f\u80fd\u969c\u5bb3\u306e\u5f15\u304d\u91d1\u3068\u306a\u308a\u3001\u30ec\u30d3\u30fc\u5c0f\u4f53\u30bf\u30f3\u30d1\u30af\u8cea\u51dd\u96c6\u4f53\u306e\u5f62\u6210\u3084\u795e\u7d4c\u5909\u6027\u306b\u95a2\u4e0e\u3059\u308b\u3002.<\/p>\n<p>\u201c\u300c\u4eca\u56de\u306e\u72ec\u5360\u63d0\u643a\u306f\u3001\u4e16\u754c\u4e2d\u306e\u5e0c\u5c11\u907a\u4f1d\u6027\u75be\u60a3\u60a3\u8005\u306e\u65e9\u671f\u767a\u898b\u3092\u52a0\u901f\u3055\u305b\u308bCENTOGENE\u306e\u5f37\u529b\u306a\u80fd\u529b\u3092\u6539\u3081\u3066\u793a\u3059\u3082\u306e\u3067\u3059\u3002\u5e0c\u5c11\u75be\u60a3\u306b\u304a\u3051\u308b\u907a\u4f1d\u5b66\u7684\u77e5\u898b\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u3001\u5f53\u793e\u306f\u30c7\u30ca\u30ea\u793e\u306b\u3088\u308b\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u60a3\u8005\u5411\u3051\u75be\u60a3\u4fee\u98fe\u85ac\u306e\u958b\u767a\u306b\u8ca2\u732e\u3067\u304d\u308b\u3068\u78ba\u4fe1\u3057\u3066\u3044\u307e\u3059\u3002CENTOGENE\u306f\u3001\u30c7\u30ca\u30ea\u793e\u306eLRRK2\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u304a\u3051\u308b\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u60a3\u8005\u767b\u9332\u3092\u52a0\u901f\u3055\u305b\u308b\u304a\u624b\u4f1d\u3044\u3092\u3044\u305f\u3057\u307e\u3059\u300d\u3068\u3001CENTOGENE\u306eCEO\u517c\u5275\u8a2d\u8005\u3067\u3042\u308b\u30a2\u30eb\u30f3\u30c8\u30fb\u30ed\u30eb\u30d5\u30b9\u535a\u58eb\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002.<\/p>\n<p>\u201c\u300c\u30c7\u30ca\u30ea\u306f\u3001\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u6cbb\u7642\u85acLRRK2\u963b\u5bb3\u5264\u3092\u7528\u3044\u305f\u81e8\u5e8a\u8a66\u9a13\u3092\u5b9f\u65bd\u3059\u308b\u6700\u521d\u306e\u4f01\u696d\u3067\u3059\u3002\u30bb\u30f3\u30c8\u30b8\u30fc\u30f3\u793e\u3068\u306e\u3053\u306e\u63d0\u643a\u306f\u3001LRRK2\u907a\u4f1d\u5b50\u306b\u5909\u7570\u3092\u6301\u3064\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u60a3\u8005\u3092\u7279\u5b9a\u3057\u3001\u8a08\u753b\u4e2d\u306e\u81e8\u5e8a\u8a66\u9a13\u306b\u7d44\u307f\u5165\u308c\u308b\u305f\u3081\u306e\u5f53\u793e\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u53d6\u308a\u7d44\u307f\u306e\u4e2d\u6838\u3092\u6210\u3059\u3082\u306e\u3067\u3059\u300d\u3068\u3001\u30c7\u30ca\u30ea\u306e\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005\u517c\u958b\u767a\u8cac\u4efb\u8005\u3067\u3042\u308b\u30ad\u30e3\u30ed\u30eb\u30fb\u30db\u30fc\u533b\u5e2b\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u30bb\u30f3\u30c8\u30b8\u30fc\u30f3\u793e\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\u3068\u6280\u8853\u306b\u611f\u9298\u3092\u53d7\u3051\u3066\u304a\u308a\u3001\u4e21\u793e\u306e\u5171\u540c\u306e\u53d6\u308a\u7d44\u307f\u306b\u3088\u3063\u3066\u3001\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u60a3\u8005\u306e\u767b\u9332\u3068\u81e8\u5e8a\u8a66\u9a13\u306e\u5b8c\u4e86\u304c\u52a0\u901f\u3055\u308c\u308b\u3068\u78ba\u4fe1\u3057\u3066\u3044\u307e\u3059\u3002\u300d\u201d<\/p>","protected":false},"excerpt":{"rendered":"<p>CENTOGENE\u3068Denali Therapeutics\uff08NASDAQ\uff1aDNLI\uff09\u306f\u672c\u65e5\u3001LRRK2\u967d\u6027\u306e\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\uff08PD\uff09\u60a3\u8005\u3092\u4e16\u754c\u898f\u6a21\u3067\u7279\u5b9a\u3057\u3001\u88ab\u9a13\u8005\u3068\u3057\u3066\u52df\u96c6\u3059\u308b\u305f\u3081\u306e\u6226\u7565\u7684\u63d0\u643a\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2402","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE and DENALI THERAPEUTICS announce strategic collaboration to recruit LRRK2 patients for clinical trials | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/jp\/centogene\u3068denali-therapeutics\u306f\u3001lrrk2\u60a3\u8005\u306e\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u53c2\u52a0\u3092\u52df\u308b\u305f\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE and DENALI THERAPEUTICS announce strategic collaboration to recruit LRRK2 patients for clinical trials | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"CENTOGENE and Denali Therapeutics (NASDAQ: DNLI) today announced a strategic collaboration for the global identification and recruitment of LRRK2-positive Parkinson\u2019s disease (PD) patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/jp\/centogene\u3068denali-therapeutics\u306f\u3001lrrk2\u60a3\u8005\u306e\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u53c2\u52a0\u3092\u52df\u308b\u305f\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-02T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE and DENALI THERAPEUTICS announce strategic collaboration to recruit LRRK2 patients for clinical trials\",\"datePublished\":\"2018-10-02T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\\\/\"},\"wordCount\":306,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\\\/\",\"name\":\"CENTOGENE and DENALI THERAPEUTICS announce strategic collaboration to recruit LRRK2 patients for clinical trials | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2018-10-02T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE and DENALI THERAPEUTICS announce strategic collaboration to recruit LRRK2 patients for clinical trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/jp\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE\u3068DENALI THERAPEUTICS\u304cLRRK2\u60a3\u8005\u306e\u81e8\u5e8a\u8a66\u9a13\u53c2\u52a0\u306b\u5411\u3051\u305f\u6226\u7565\u7684\u63d0\u643a\u3092\u767a\u8868\uff5cCENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/jp\/centogene\u3068denali-therapeutics\u306f\u3001lrrk2\u60a3\u8005\u306e\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u53c2\u52a0\u3092\u52df\u308b\u305f\/","og_locale":"ja_JP","og_type":"article","og_title":"CENTOGENE and DENALI THERAPEUTICS announce strategic collaboration to recruit LRRK2 patients for clinical trials | CENTOGENE","og_description":"CENTOGENE and Denali Therapeutics (NASDAQ: DNLI) today announced a strategic collaboration for the global identification and recruitment of LRRK2-positive Parkinson\u2019s disease (PD) patients.","og_url":"https:\/\/www.centogene.com\/jp\/centogene\u3068denali-therapeutics\u306f\u3001lrrk2\u60a3\u8005\u306e\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u53c2\u52a0\u3092\u52df\u308b\u305f\/","og_site_name":"CENTOGENE","article_published_time":"2018-10-02T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"admincg","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE and DENALI THERAPEUTICS announce strategic collaboration to recruit LRRK2 patients for clinical trials","datePublished":"2018-10-02T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\/"},"wordCount":306,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"ja","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\/","url":"https:\/\/www.centogene.com\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\/","name":"CENTOGENE\u3068DENALI THERAPEUTICS\u304cLRRK2\u60a3\u8005\u306e\u81e8\u5e8a\u8a66\u9a13\u53c2\u52a0\u306b\u5411\u3051\u305f\u6226\u7565\u7684\u63d0\u643a\u3092\u767a\u8868\uff5cCENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2018-10-02T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-and-denali-therapeutics-announce-strategic-collaboration-to-recruit-lrrk2-patients-for-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE and DENALI THERAPEUTICS announce strategic collaboration to recruit LRRK2 patients for clinical trials"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"\u30bb\u30f3\u30c8\u30b8\u30fc\u30f3","description":"\u7cbe\u5bc6\u533b\u7642\u306e\u6307\u91dd","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"\u30bb\u30f3\u30c8\u30b8\u30fc\u30f3","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"admincg","url":"https:\/\/www.centogene.com\/jp\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/jp\/wp-json\/wp\/v2\/posts\/2402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/jp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/jp\/wp-json\/wp\/v2\/comments?post=2402"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/jp\/wp-json\/wp\/v2\/posts\/2402\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/jp\/wp-json\/wp\/v2\/media?parent=2402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/jp\/wp-json\/wp\/v2\/categories?post=2402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/jp\/wp-json\/wp\/v2\/tags?post=2402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}